26.95
price down icon1.64%   -0.52
 
loading
전일 마감가:
$27.47
열려 있는:
$27.2
하루 거래량:
1.55M
Relative Volume:
0.15
시가총액:
$10.43B
수익:
$3.14B
순이익/손실:
$-3.36B
주가수익비율:
-3.0871
EPS:
-8.73
순현금흐름:
$-4.03B
1주 성능:
-15.96%
1개월 성능:
-11.38%
6개월 성능:
-19.61%
1년 성능:
-67.17%
1일 변동 폭
Value
$26.78
$27.48
1주일 범위
Value
$26.56
$31.84
52주 변동 폭
Value
$23.15
$91.99

모더나 Stock (MRNA) Company Profile

Name
명칭
Moderna Inc
Name
전화
(617) 714-6500
Name
주소
325 BINNEY STREET, CAMBRIDGE
Name
직원
5,800
Name
트위터
@moderna_tx
Name
다음 수익 날짜
2025-08-01
Name
최신 SEC 제출 서류
Name
MRNA's Discussions on Twitter

MRNA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
MRNA
Moderna Inc
26.97 10.75B 3.14B -3.36B -4.03B -8.73
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
384.33 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.58B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
418.95 54.99B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
677.96 42.25B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
293.14 32.93B 3.81B -644.79M -669.77M -6.24

모더나 Stock (MRNA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-13 개시 Citigroup Neutral
2025-02-18 다운그레이드 Barclays Overweight → Equal Weight
2025-01-29 다운그레이드 Goldman Buy → Neutral
2024-12-18 다운그레이드 Argus Buy → Hold
2024-12-10 재개 BofA Securities Underperform
2024-11-19 개시 Berenberg Hold
2024-11-18 업그레이드 HSBC Securities Hold → Buy
2024-11-15 개시 Wolfe Research Underperform
2024-10-17 개시 Bernstein Mkt Perform
2024-09-13 다운그레이드 JP Morgan Neutral → Underweight
2024-09-13 다운그레이드 Jefferies Buy → Hold
2024-09-13 다운그레이드 Oppenheimer Outperform → Perform
2024-08-28 업그레이드 HSBC Securities Reduce → Hold
2024-08-07 업그레이드 Deutsche Bank Sell → Hold
2024-08-05 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2024-02-26 다운그레이드 HSBC Securities Hold → Reduce
2024-01-02 업그레이드 Oppenheimer Perform → Outperform
2023-11-29 개시 Canaccord Genuity Hold
2023-11-03 업그레이드 HSBC Securities Reduce → Hold
2023-11-02 다운그레이드 Deutsche Bank Hold → Sell
2023-08-04 다운그레이드 TD Cowen Outperform → Market Perform
2023-08-03 다운그레이드 Deutsche Bank Buy → Hold
2023-07-24 개시 William Blair Mkt Perform
2023-07-14 개시 HSBC Securities Reduce
2023-06-26 업그레이드 UBS Neutral → Buy
2023-04-26 개시 Guggenheim Neutral
2023-03-13 업그레이드 TD Cowen Market Perform → Outperform
2023-03-02 개시 RBC Capital Mkts Outperform
2023-02-24 다운그레이드 SVB Securities Market Perform → Underperform
2022-12-19 업그레이드 Jefferies Hold → Buy
2022-12-14 다운그레이드 Chardan Capital Markets Buy → Neutral
2022-10-21 업그레이드 SVB Leerink Underperform → Mkt Perform
2022-09-08 업그레이드 Deutsche Bank Hold → Buy
2022-02-01 업그레이드 Redburn Sell → Neutral
2022-01-26 업그레이드 Deutsche Bank Sell → Hold
2022-01-21 업그레이드 BofA Securities Underperform → Neutral
2022-01-21 개시 UBS Neutral
2021-12-07 개시 Cowen Market Perform
2021-11-09 개시 Wolfe Research Outperform
2021-10-22 개시 Deutsche Bank Sell
2021-10-15 업그레이드 Piper Sandler Neutral → Overweight
2021-08-06 다운그레이드 Oppenheimer Outperform → Perform
2021-08-06 다운그레이드 Piper Sandler Overweight → Neutral
2021-07-15 재확인 Jefferies Hold
2021-02-01 다운그레이드 BofA Securities Neutral → Underperform
2020-12-16 다운그레이드 Jefferies Buy → Hold
2020-12-16 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-12-09 다운그레이드 Needham Buy → Hold
2020-11-23 개시 Wells Fargo Equal Weight
2020-11-17 다운그레이드 BMO Capital Markets Outperform → Market Perform
2020-09-08 다운그레이드 SVB Leerink Mkt Perform → Underperform
2020-07-23 개시 SVB Leerink Mkt Perform
2020-07-20 다운그레이드 JP Morgan Overweight → Neutral
2020-07-13 개시 Jefferies Buy
2020-06-30 개시 Argus Buy
2020-06-08 개시 Barclays Overweight
2020-04-30 개시 BMO Capital Markets Outperform
2020-03-05 다운그레이드 BofA/Merrill Buy → Neutral
2019-12-03 재개 BofA/Merrill Buy
2019-10-25 개시 ROTH Capital Buy
2019-04-05 개시 Chardan Capital Markets Buy
모두보기

모더나 주식(MRNA)의 최신 뉴스

pulisher
08:08 AM

RFK Jr. Axes 22 mRNA Vaccine Projects Under BARDA - BioSpace

08:08 AM
pulisher
07:12 AM

ABC Arbitrage SA Takes Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

07:12 AM
pulisher
07:05 AM

HHS halts funding for mRNA vaccine activities (MRNA:NASDAQ) - Seeking Alpha

07:05 AM
pulisher
06:14 AM

RFK Jr. Halts $500 Million In mRNA Vaccine Projects Backed By Pfizer, Moderna: 'We're Prioritizing Safer, Broader Strategies' - Benzinga

06:14 AM
pulisher
03:35 AM

Moderna Stock: Is Wall Street Bullish Or Bearish? - Barchart.com

03:35 AM
pulisher
03:17 AM

Envestnet Asset Management Inc. Sells 12,212 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

03:17 AM
pulisher
Aug 05, 2025

Wealthquest Corp Buys Shares of 36,587 Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Aug 05, 2025
pulisher
Aug 05, 2025

Moderna, Pfizer, Sanofi In Focus As US Winds Down mRNA Vaccine Plans; Retail Turns Bearish On AstraZeneca - Stocktwits

Aug 05, 2025
pulisher
Aug 05, 2025

US Health Department Pulls Back on Funding mRNA Vaccine Research - Bloomberg.com

Aug 05, 2025
pulisher
Aug 05, 2025

US health agency to wind down mRNA vaccine development - Reuters

Aug 05, 2025
pulisher
Aug 05, 2025

14,589 Shares in Moderna, Inc. (NASDAQ:MRNA) Purchased by Banque Cantonale Vaudoise - MarketBeat

Aug 05, 2025
pulisher
Aug 05, 2025

Barclays Has Lowered Expectations for Moderna (NASDAQ:MRNA) Stock Price - MarketBeat

Aug 05, 2025
pulisher
Aug 05, 2025

Moderna: RSV Upside Slim, Cash Burn Heavy (NASDAQ:MRNA) - Seeking Alpha

Aug 05, 2025
pulisher
Aug 05, 2025

Let’s make a deal? Big Pharma execs express varying views on their M&A future - PharmaVoice

Aug 05, 2025
pulisher
Aug 05, 2025

Lipid Nanoparticles Market Industry Trends, Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2034 - GlobeNewswire Inc.

Aug 05, 2025
pulisher
Aug 05, 2025

Zurcher Kantonalbank Zurich Cantonalbank Sells 134,443 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Aug 05, 2025
pulisher
Aug 05, 2025

Moderna, Inc. (NASDAQ:MRNA) Holdings Cut by Pacer Advisors Inc. - MarketBeat

Aug 05, 2025
pulisher
Aug 04, 2025

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1 - The Florida Times-Union

Aug 04, 2025
pulisher
Aug 04, 2025

UK Court of Appeal Confirms Moderna’s EP’949 Patent is Valid and Infringed by Pfizer/BioNTech - Pocono Record

Aug 04, 2025
pulisher
Aug 04, 2025

Moderna Reports Second Quarter 2025 Financial Results and Provides Business Updates - The Courier-Journal

Aug 04, 2025
pulisher
Aug 04, 2025

Moderna Seeks To Be Cleared In $5B COVID Vax Patent Case - Law360

Aug 04, 2025
pulisher
Aug 04, 2025

BofA Securities lowers Moderna stock price target to $24 on COVID reliance - Investing.com

Aug 04, 2025
pulisher
Aug 04, 2025

EU regulator backs Moderna's updated COVID vaccine - MSN

Aug 04, 2025
pulisher
Aug 04, 2025

Moderna Tops Vaccine Expectations But Trims Future Outlook - Finimize

Aug 04, 2025
pulisher
Aug 04, 2025

Moderna stock falls as UBS reiterates Buy rating amid cost cuts - Investing.com Canada

Aug 04, 2025
pulisher
Aug 04, 2025

How the U.S. mRNA Therapeutics Market Will Evolve by 2032 - openPR.com

Aug 04, 2025
pulisher
Aug 04, 2025

Moderna Q2 Earnings Review: Downsizing Triggers Selloff, But I'm Long-Term Bullish (MRNA) - Seeking Alpha

Aug 04, 2025
pulisher
Aug 04, 2025

Moderna (NASDAQ:MRNA) Announces Quarterly Earnings Results - MarketBeat

Aug 04, 2025
pulisher
Aug 04, 2025

OVERSEA CHINESE BANKING Corp Ltd Has $1.16 Million Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Aug 04, 2025
pulisher
Aug 04, 2025

XTX Topco Ltd Raises Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Aug 04, 2025
pulisher
Aug 03, 2025

What is Moderna Inc. company’s growth strategyPowerful profit generation - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Private Advisor Group LLC Sells 13,174 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Aug 03, 2025
pulisher
Aug 03, 2025

What analysts say about Moderna Inc. stockMaximize your portfolio’s growth potential - jammulinksnews.com

Aug 03, 2025
pulisher
Aug 03, 2025

Moderna: Is Now the Time to Buy the Deep Value Dip? - FXEmpire

Aug 03, 2025
pulisher
Aug 03, 2025

Moderna’s Hold Rating: Navigating Revenue Adjustments and Product Development Uncertainties - TipRanks

Aug 03, 2025
pulisher
Aug 03, 2025

What are Moderna Inc. company’s key revenue driversHigh-octane gains - jammulinksnews.com

Aug 03, 2025
pulisher
Aug 03, 2025

Novo Nordisk, United Parcel Service, And Moderna Are Among Top 10 Large Cap Losers Last Week (July 28-August 1): Are The Others In Your Portfolio? - Benzinga

Aug 03, 2025
pulisher
Aug 03, 2025

When is Moderna Inc. stock expected to show significant growthHigh-octane financial growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Moderna Inc. a growth stock or a value stockBuild wealth faster with expert stock selection - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

What institutional investors are buying Moderna Inc. stockUnrivaled growth potential - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Letko Brosseau & Associates Inc. Has $25.41 Million Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Aug 02, 2025
pulisher
Aug 02, 2025

Moderna Sees Unusually High Options Volume (NASDAQ:MRNA) - MarketBeat

Aug 02, 2025
pulisher
Aug 02, 2025

Moderna (NASDAQ:MRNA) Shares Gap DownTime to Sell? - MarketBeat

Aug 02, 2025
pulisher
Aug 02, 2025

Moderna, Inc. (NASDAQ:MRNA) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 02, 2025
pulisher
Aug 02, 2025

Moderna, Inc. (NASDAQ:MRNA) Shares Acquired by Federated Hermes Inc. - MarketBeat

Aug 02, 2025
pulisher
Aug 02, 2025

Moderna Inc (MRNA) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Cost ... - Yahoo Finance

Aug 02, 2025
pulisher
Aug 02, 2025

Moderna Inc (MRNA) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Cost Reductions and New Approvals - GuruFocus

Aug 02, 2025
pulisher
Aug 02, 2025

Moderna’s Q2 2025 Financial Results and Outlook - TipRanks

Aug 02, 2025
pulisher
Aug 01, 2025

Moderna Outpaces Losses With Cost Cuts And New Plans - Finimize

Aug 01, 2025
pulisher
Aug 01, 2025

Moderna's Q2 Earnings and Strategic Cost Cuts: A Path to Sustainable Recovery? - AInvest

Aug 01, 2025
pulisher
Aug 01, 2025

Moderna: Q2 Earnings Snapshot - Norwalk Hour

Aug 01, 2025

모더나 (MRNA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$77.25
price down icon 0.70%
$37.48
price down icon 1.28%
$112.02
price up icon 0.06%
$28.73
price down icon 1.59%
$111.32
price up icon 0.19%
biotechnology ONC
$298.31
price down icon 3.03%
자본화:     |  볼륨(24시간):